These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2205896)

  • 1. 5-Hydroxytryptamine: new receptors and novel drugs for gastrointestinal motor disorders.
    Costall B; Naylor RJ
    Scand J Gastroenterol; 1990 Aug; 25(8):769-87. PubMed ID: 2205896
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serotonin may be the key to the treatment of "irritable bowel disease"].
    Sjövall H
    Lakartidningen; 2001 May; 98(18):2166-71. PubMed ID: 11402594
    [No Abstract]   [Full Text] [Related]  

  • 3. The importance of 5-hydroxytryptamine receptors in the gut.
    Read NW; Gwee KA
    Pharmacol Ther; 1994; 62(1-2):159-73. PubMed ID: 7991641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin and the GI tract.
    Hasler WL
    Curr Gastroenterol Rep; 2009 Oct; 11(5):383-91. PubMed ID: 19765366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent insights into the pathogenesis of abdominal symptoms in functional bowel disorders].
    Cervio E; Rondanelli M; Balestra B; Dellabianca A; Agazzi A; Giacosa A; Tonini M
    Recenti Prog Med; 2007 Feb; 98(2):69-73. PubMed ID: 17439064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cisapride and other prokinetic agents in the treatment of gastroenterological diseases].
    Ryss ES; Fishzon-Ryss IuI
    Ter Arkh; 1995; 67(2):58-61. PubMed ID: 7725263
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of serotonin in gastrointestinal physiology and pathology.
    Cirillo C; Vanden Berghe P; Tack J
    Minerva Endocrinol; 2011 Dec; 36(4):311-24. PubMed ID: 22322654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of serotonin: what a clinician should know.
    De Ponti F
    Gut; 2004 Oct; 53(10):1520-35. PubMed ID: 15361507
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical utility of pharmacological agents that act at serotonin receptors.
    Peroutka SJ; Sleight AJ; McCarthy BG; Pierce PA; Schmidt AW; Hekmatpanah CR
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):253-62. PubMed ID: 2562495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 2-methyl-5-hydroxytryptamine on motility of the isolated guinea-pig colon.
    Ishizawa M
    Nihon Heikatsukin Gakkai Zasshi; 1990 Oct; 26(5):285-7. PubMed ID: 2103933
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs.
    Nagakura Y; Kamato T; Nishida A; Ito H; Yamano M; Miyata K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):489-98. PubMed ID: 8740141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of prokinetic agents in special populations.
    Horn JR
    Am J Health Syst Pharm; 1996 Nov; 53(22 Suppl 3):S27-9. PubMed ID: 8931828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility.
    Scarpignato C; Pelosini I
    Can J Gastroenterol; 1999 Mar; 13 Suppl A():50A-65A. PubMed ID: 10202210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal prokinetic activity of serotonergic agents.
    VanSyoc ML; Wong AG; Perry MR; Smith WL
    Proc West Pharmacol Soc; 1992; 35():117-21. PubMed ID: 1502210
    [No Abstract]   [Full Text] [Related]  

  • 15. Serotonin: a review.
    Mohammad-Zadeh LF; Moses L; Gwaltney-Brant SM
    J Vet Pharmacol Ther; 2008 Jun; 31(3):187-99. PubMed ID: 18471139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From metoclopramide to selective gut motility stimulants and 5-HT3 receptor antagonists.
    Sanger GJ; King FD
    Drug Des Deliv; 1988 Dec; 3(4):273-95. PubMed ID: 3076395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptors in the regulation of gut motility in the ferret.
    Nagakura Y; Kiso T; Ito H; Miyata K; Yamaguchi T
    Life Sci; 2000 May; 66(24):PL331-8. PubMed ID: 10864103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Hydroxytryptamine effects in the gut: the 3, 4, and 7 receptors.
    Tonini M
    Neurogastroenterol Motil; 2005 Oct; 17(5):637-42. PubMed ID: 16185301
    [No Abstract]   [Full Text] [Related]  

  • 19. Serotonin: its role and receptors in enteric neurotransmission.
    Gershon MD
    Adv Exp Med Biol; 1991; 294():221-30. PubMed ID: 1772068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gastrointestinal motility disorders and drugs: opioids, calcium antagonists, nitrates, peptides, prostaglandins and 5-hydroxytryptaminergic drugs (part II)].
    Jovanović-Mićić D; Samardzić R; Beleslin B
    Srp Arh Celok Lek; 1994; 122(3-4):88-92. PubMed ID: 17972818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.